Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

FDA accepts OPKO's resubmitted NDA for calcifediol

April 28, 2016

FDA grants fast track designation for recAP in acute kidney injury

April 27, 2016

Boehringer Ingelheim initiates phase I study of anti-CX3CR1 Nanobody from Ablynx alliance

April 21, 2016

TGI and Quark enter discovery and development collaboration

April 15, 2016

Eli Lilly develops PDE4B inhibitors

April 4, 2016

Kyorin and Kissei sign codevelopment and co-marketing agreement for KRP-114V in Japan

March 31, 2016

Positive topline results from pivotal phase III study of ferric citrate

March 30, 2016

First patients dosed in Quark Pharmaceuticals' pivotal studies

March 15, 2016

Astellas Pharma discloses muscarinic M3 receptor PAMs

March 14, 2016

Tesevatinib receives FDA orphan drug designation for the treatment of ARKPD

March 4, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.